Asuragen announce the launch of AmplideX PCR/CE DMPK Kit for myotonic dystrophy

Last updated: 03rd February, 2022

Products are for professional/laboratory use only.

Abacus dx would like to update you with the latest products from Asuragen.

Asuragen have recently announced the launch of AmplideX® PCR/CE DMPK. This kit aims to simplify the analysis of repeat expansions within the DMPK gene, which is implicated in myotonic dystrophy type 1 (DM1).
As part of our release of AmplideX® PCR/CE DMPK into the ANZ market, Abacus dx would like your help and feedback on this product and use in the diagnosis of myotonic dystrophy type 1.

Find out more about AmplideX PCR/CE DMPK Kit

View Flyer >

Benefits of AmplideX® PCR/CE DMPK Kit include:

  • Sensitive detection and accurate sizing of CTG repeat expansion in the DMPK gene
  • Detection of very large repeat expansions – up to 2000 repeats
  • PCR-only workflow enables rapid and precise analysis of large repeats, eliminating the need for Southern Blot
  • All-inclusive test kit containing all the necessary reagents to go from sample to result in a single-day workflow

For feedback or more information on this kit

Contact our Product Manager >

Related Products:

Request a Quote

Request Quote

Go BackGo Back